Cellular and Molecular Biology 2019

1 papers

Top Research Directions

The 5 research directions with Cellular and Molecular Biology 2019 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Achieving Therapeutic Selectivity in Cancer Chemotherapy1100.0%
2Modulating the Stoichiometric Balance of Bcl-2 Family Proteins1100.0%
3Physiological Validation of Reductionist Molecular Mechanisms1100.0%
4Quantifying Apoptosis Stages via Flow Cytometry1100.0%
5Targeting Mitochondrial Membrane Potential to Trigger Intrinsic Apoptosis1100.0%

Download all directions as CSV

Institutions

Institutions credited by Cellular and Molecular Biology 2019 papers: a paper credits every institution named in its affiliations, once. 2 institutions share 1 credited papers.

#InstitutionPapersShare
103108sf43 1100.0%
2Nanjing Medical University 1100.0%

Download all institutions as CSV

About this data

Papers. Cellular and Molecular Biology 2019 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Cellular and Molecular Biology 2019”, https://lacuna.tiptreesystems.com/venue/cellular-and-molecular-biology/2019.

Impactful Papers

Papers from Cellular and Molecular Biology 2019 that shaped research clusters.

Influential

Papers

Title
Ent-Dihydrotucumanoic acid promotes apoptosis in PC-3 human prostate cancer cells